Arcus Biosciences RCUS
NYSE RCUS
$23.75 +1.61 (+7.27%)
At close: Oct 20, 2026 · 4:00 PM EDT

Arcus Biosciences (RCUS) Receivables (2017 - 2019)

Updated

Arcus Biosciences (RCUS) posted Receivables of $62,000 for Q2 2019, down 84.2% from $393,000 a year earlier.

Analysis

Arcus Biosciences (RCUS) Receivables (2017 - 2019) Analysis & Trends

At the end of FY2018, Arcus Biosciences' Receivables came in at $183,000, up 266.0% from FY2017.

  • In prior years, Arcus Biosciences' Receivables was $50,000 in FY2017.
  • The Q2 2019 figure stands as the lowest quarterly Receivables since Q4 2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 23.48 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 19.05 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 13.82 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn 12.56 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 9.64 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 15.68 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 10.23 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn 5.06 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn 12.49 Bn
10 Arcus Biosciences 3.00 Bn -337.34 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2019 62,000.00
Dec 31, 2018 183,000.00
Sep 30, 2018 5.10 Mn
Jun 30, 2018 393,000.00
Dec 31, 2017 50,000.00
API Access

Arcus Biosciences Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=RCUS&period=max&api_key=YOUR_API_KEY